Nomura Holdings Inc Biomarin Pharmaceutical Inc Put Options Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $227,766 - $309,672	-3,300 Reduced 30.84%	7,400 $520,000
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $3.8 Million - $4.71 Million	-51,100 Reduced 82.69%	10,700 $880,000
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $5.18 Million - $6.12 Million	61,800 New	61,800 $5.4 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $12.5 Million - $15.7 Million	-185,000 Reduced 82.22%	40,000 $2.59 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $17.1 Million - $22.3 Million	225,000 New	225,000 $0

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.